반응식
Cl[CH2:2][CH:3]1[CH2:9][N:8]([CH:10]2[CH2:15][CH2:14][CH2:13][CH2:12][CH2:11]2)[C:7](=[O:16])[C:6]2[CH:17]=[CH:18][CH:19]=[N:20][C:5]=2[O:4]1.[CH3:21][NH:22][CH3:23].[C:24]([OH:29])(=[O:28])[C:25]([OH:27])=[O:26]>C(O)(C)C>[C:24]([OH:29])(=[O:28])[C:25]([OH:27])=[O:26].[CH:10]1([N:8]2[C:7](=[O:16])[C:6]3[CH:17]=[CH:18][CH:19]=[N:20][C:5]=3[O:4][CH:3]([CH2:2][N:22]([CH3:23])[CH3:21])[CH2:9]2)[CH2:15][CH2:14][CH2:13][CH2:12][CH2:11]1참가 물질
5
실험 절차
Utilizing the procedure of Example 10, 2-(chloromethyl)-4-cyclohexyl-2,3-dihydropyrido[3,2-f][1,4]oxazepin-5(4H)-one (Intermediate 35) is reacted with 40% aqueous dimethylamine and reacted with oxalic acid in isopropyl alcohol.
출처 및 근거
- ORD 기록
- ord-0d2990c41d374c739bca2b65ac7f2b1e
- 출처 데이터셋
- uspto-grants-1986_08
- 특허 번호
- US04604388
연결된 노트
불러오는 중…